The ATM gene and the radiobiology of ataxia-telangiectasia

International Journal of Radiation Biology

Volumn 69, Issue 5, 1996, Pages 527-537

  Jorgensen, T J ^a   Shiloh, Y ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; DNA REPAIR; EARLY DIAGNOSIS; GENE MAPPING; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; IMMUNE DEFICIENCY; IONIZING RADIATION; PREDICTION; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; XERODERMA PIGMENTOSUM;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; DNA; DNA-BINDING PROTEINS; GENES, P53; HOMOZYGOTE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0029899035     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096145535     Document Type: Review

References (104)

1. ASTOR, M. B. and MORSE, T. D., 1989, Rapid repair of potentially lethal damage in normal and ataxia telangiectasia tell lines. International Journal of Radiation Biology, 55, 631-639.
2. BEAMISH, H., KHANNA, K. K. and LAVIN, M. F., 1994, Ionizing radiation and cell cycle progression in ataxia telangiectasia. Radiation Research, 138(suppl.), S130-133.
3. BEAMISH, H. and LAVIN, M. F., 1904, Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. International Journal of Radiation Biology, 65, 175-184.
4. BECKMAN, J. S., 1994, Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Annals of the New York Academy of Science, 738, 69-75.
5. BECKMAN, J. S., CHEN, J., CROW, J. P. and YE, Y. Z., 1994, Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Progress in Brain Research, 103, 371-380.
6. BIEDERMANN, K. A., SUN, J. R., GIACCIA, A. J., TOSTO, L. M. and Brown, J. M., 1991, suid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proceedings of the National Academy of Science, USA, 88, 1394-1397.
7. BLOCHER, D., SIGUT, D. and HANNAN, M. A., 1991, Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. International Journal of Radiation Biology, 60, 791-802.
8. BOIGE, J. D., Jr and MILLER, R. W., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1357-1358.
9. BOUFFLER, S. D., KEMP, C. J., BALMAIN, A. and COX, R., 1995, Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Research, 55, 3883-3889.
10. BRIDGES, B. A. and ARLETT, C. F., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1357.
11. 1-arresting rapamycin-receptor complex. Nature, 369, 750-758.
12. BROWN, E.J., BEAL, P. A., KEITH, C. T., CHEN, J., SHIN, T. B. and SCHREIBER, S. L., 1995, Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature, 377, 441-446.
13. CIMPRICH, K. A., SHIN, T. B., KEITH, C. T., and SCHREIBER, S. L., 1996, cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proceedings of the National Academy of Sciences USA, 93, 2850-2855.
14. CLEETER, M. W., COOPER, J. M., DARLEY-USMAR, V. M., MONCADA, S. and SCHAPIRA, A. H., 1994, Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenrative disease. FEBS Letters, 345, 50-54.
15. CORNFORTH, M. N. and BEDFORD, J. S., 1985, On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science, 227, 1589-1591.
16. CORNFORTH, M. N. and BEDFORD, J. S., 1987, A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiation Research, 111, 385-405.
17. DECKWERIH, T. L. and JOHNSON, E. M. Jr., 1993, Neurotrophic factor deprivation-induced death. Annals of the New York Academy of Science, 679, 121-131.
18. DIVECHA, N. and IRVINE, R. F., 1995, Phospholipid signaling. Cell, 80, 269-278.
19. DOWNWARD, J., 1995, Signal transduction: a target for PI(3) kinase. Nature, 376, 553-554.
20. EASTON, D. F., 1994, Cancer risk in A-T heterozygotes. International Journal of Radiation Biology, 66(suppl.), S177-182.
21. FULOP, G. M. and PHILLIPS, R. A., 1990, The scid mutation in mice causes a general defect in DNA repair. Nature, 347, 479-482.
22. GATTI, R. A., BODER, E., VINTERS, H. V., SPARKES, R. S., NORMAN, A. and LANGE, K., 1991, Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore), 70, 99-117.
23. GILAD, S., KHOSRAVI, R., SHKEDY, D., UZIEL, T., ZIV, Y., SAVITSKY, K., ROTMAN, G., SMITH, S., CHESSA, L., JORGENSEN, T. J., HARNIK, R., FRYDMAN, M., SANAL, O., PORTNOI, S., GOLDWICZ, Z., JASPERS, N. G. J., GATTI, R. A., LENOIR, G., LAVIN, M. F., TATSUMI, K., WEGNER, R. D., SHILOH, Y. and BAR-SHIRA, A., 1996, Predominance of null mutations in ataxia-telangiectasia. Human Molecular Genetics, 5, 433-440.
24. GREENWELL, P. W., KRONMAL, S. L., PORTER, S. E., GASSENHUBER, J., OBERMAIER, B. and PETERS, T. D., 1995, TEL1, a gene involved in controlling telemere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell, 82, 823-829.
25. HALL, E. J., GEARD, C. R. and BRENNER, D. J., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1358-1359.
26. HARI, K. L., SANTERRE, A., SEKELSKY, J. J., MCKIM, K. S., BOYD, J. B. and HAWLEY, R. S., 1995, The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telangiectasia gene. Cell, 82, 815-821.
27. HARNDEN, D. G., 1994, The nature of ataxia-telangiectasia: Problems and perspectives. International Journal of Radiation Biology, 66(suppl.), S13-19.
28. HARTLEY, K. O., GELL, D., SMITH, G. C. M., ZHANG, H., DIVECHA, N., CONNELLY, M. A., ADMON, A., LEES-MILLER, S. P., ANDERSON, C. W. and JACKSON, S. P., 1995, DNA-dependent protein kinase catalytic subunit: A relative of phosphotidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell, 82, 849-856.
29. HARTWELL, L. H. and KASTAN, M. B., 1994, Cell cycle control and cancer. Science, 266, 1821-1828.
30. HENDRICKSON, E. A., QIN, X.-Q., BUMP, E. A., SCHATZ, D. G., OETTINGER, M. and WEAVER, D. T., 1991, A link between double-strand break-related repair and V(D)J recombination: the scid mutation. Proceedings of the National Academy of Sciences, USA, 88, 4061-4065.
31. HEPPEL, A., BUTTERWORTH, S. V., HOLLIS, R. J., KENNAUGH, A. A., BEATTY, D. W. and TAYLOR, A. M. R., 1988, Breakage of the T cell receptor alpha chain locus in non-malignant clones from patients with ataxia-telangiectasia. Human Genetics, 79, 360-364.
32. HOULDSWORTH, J., COHEN, D., SINGH, S. and LAVIN, M. F., 1991, The response of ataxia-telangiectasia lymphoblastoid cells to neutron irradiation. Radiation Research, 125, 277-282.
33. HOULSWORTH, J. and LAVIN, M. F., 1980, Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia. Nucleic Acids Research, 8, 3709-3720.
34. HUNTER, T., 1995, When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell, 83, 1-4.
35. JASPERS, N. G. J. and BOOTSMA, D., 1982, Genetic heterogeneity in ataxia telangiectasia studied by cell fusion. Proceedings of the National Academy of Sciences, USA, 79, 2641.
36. JASPERS, N. G., PAINTER, R. B., PATERSON, M. C., KIDSON, C. and INOUE, T., 1985, Complementation analysis of ataxia-telangiectasia. In: Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood. Edited by R. A. Gatti and M. Swift (New York: Alan R. Liss, Inc.), pp. 147-162.
37. KASTAN, M. B., ZHAN, Q., EL-DEIRY, W. S., CARRIER, F., JACKS, T., WALSH, W. V., PLUNKETT, B. S., VOGELSTEIN, B. and FORNACE, A. J., Jr, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
38. KEITH, C. T. and SCHREIBER, S. L., 1995, PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science, 270, 50-51.
39. 1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene, 11, 609-618.
40. KIRCHGESSNER, C. U., PATIL, C. K., EVANS, J. W., CUOMO, C. A., FRIED, L. M., CARTER, T., OETTINGER, M. A. and BROWN, J. M., 1995, DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science, 267, 1178-1183.
41. KOJIS, T. L., GATTI, R. A. and SPARKES, R. S., 1991, The cytogenetics of ataxia telangiectasia. Cancer Genetics and Cytogenetics, 56, 143-156.
42. KOMATSU, K., OKUMURA, Y., KODAMA, S., YOSHIDA, M. and MILLER, R. C., 1989, Lack of correlation between radiosensitivity and inhibition of DNA synthesis in hybrids (A-T x HeLa). International Journal of Radiation Biology, 56, 863-867.
43. KULLER, L. H. and MODAN, B., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1357.
44. LAMBERT, W. C., KOLBER, L. R., GORELLI, L. A., MUGLIA, J. J. and KARDASHIAN, J. F., 1982, Epidermoid carcinoma of the oral cavity following diagnostic roentgenographic examination in a patient with ataxia-telangiectasia. Clinical Preventive Dentistry, 4, 3-8.
45. LAND, C. E., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1359-1360.
46. LAVIN, M. F. and SCHROEDER, A. L., 1988, Damage-resistant DNA synthesis in eukaryotes. Mutation Research, 193, 193-206.
47. LEE, J. M. and BERNSTEIN, A., 1993, p53 Mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 5742-5746.
48. LEES-MILLER, S. P., GODBOUT, R., CHAN, D. W., WEINFELD, M., DAY, R. S., III, BARRON, G. M. and ALLALUNIS-TURNER, J., 1995, Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science, 267, 1183-1185.
49. LEHMANN, A. R., ARLETT, C. F., BURKE, J. F., GREEN, M. H. L., JAMES, M. R. and LOWE, J. E., 1986, A derivative of an ataxia-telangiectasia (A-T) cell line with normal radio-sensitivity but A-T-like inhibition of DNA synthesis. International Journal of Radiation Biology, 49, 639-643.
50. LINET, M. S., 1985,The Leukaemias: Epidemiologic Aspects (Oxford University Press, New York).
51. LOWE, S. W., SCHMITT, E. M., SMITH, S. W., OSBORNE, B. A. and JACKS, T., 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
52. LU, X. and LANE, D. P., 1993, Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell, 75, 765-778.
53. MARTIN, D. P., ITO, A., HORIGOME, K., LAMPE, P. A. and JOHNSON, E. M. Jr, 1992, Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. Journal of Neurobiology, 23, 1205-1220.
54. METCALFE, J. A., HEPPELL-PARTON, A., MCCONVILLE, C. M. and TAYLOR, A. M. R., 1991, Characterization of a B-lymphocyte t(2;14) (p11;q32) translocation from an ataxia telangiectasia patient conferring a proliferative advantage on cells in vitro. Cytogenetics and Cell Genetics, 56, 91-98.
55. MEYN, M. S., 1995, Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Research, 55, 5991-6001.
56. MEYN, M. S., STRASFELD, L. and ALLEN, C., 1994, Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. International Journal of Radiation Biology, 66(suppl.). S141-149.
57. MILLER, R. D., HOGG, J., OZAKI, J. H., GELL, D., JACKSON, S. P. and RIBLET, R., 1995, Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proceedings of the National Academy of Sciences, USA, 92, 10792-10795.
58. MIRZAYANS, R. and PATERSON, M. C., 1991, Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide. Carcinogenesis, 12, 19-24.
59. MORROW, D. M., TAGLE, D. A., SHILOH, Y., COLLINS, F. S. and HIETER, P., 1995, TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell, 82, 831-840.
60. MOUNT, H. T. J., DREYFUS, C. F. and BLACK, I. B., 1995, Purkinje cell survival is differentially regulated by metabotropic and ionotropic excitatory amino acid receptors. Journal of Neuroscience, 13, 3173-179.
61. MURNANE, J. P. and PAINTER, R. B., 1982, Complementation of the defects in DNA synthesis in irradiated and unirradiated ataxia-telangiectasia cells. Proceedings of the National Academy of Sciences, USA, 79, 1960-1963.
62. National Research Council Committee on the Biological Effects of Ionizing Radiation, 1990, Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V) (National Academy Press, Washington).
63. PAINTER, R. B., 1986, Inhibition of mammalian cell DNA synthesis by ionizing radiation. International Journal of Radiation Biology, 49, 771-781.
64. PAINTER, R. B. and YOUNG, B. R., 1980, Radiosensitivity in ataxia-telangiectasia: a new explanation. Proceedings of the National Academy of Sciences, USA, 77, 7315-7317.
65. PANDITA, T. K. and HITTELMAN, W. N., 1994, Increased initial levels of chromosome damage and heterogeneous chromosome repair in ataxia telangiectasia heterozygote cells. Mutation Research and Fundamental Mechanisms of Mutagenesis, 310, 1-13.
66. PANDITA, T. K., PATHAK, S. and GEARD, C. R., 1995, Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenetics and Cell Genetics, 71, 86-93.
67. PATERSON, M. C., MACFARLANE, S. J., GENTNER, N. E. and SMITH, B. P., 1985, Cellular hypersensitivity to chronic gamma-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes. In: Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood. Edited by R.A. Gatti and M. Swift. (Liss, New York), pp. 73-87.
68. PAULOVICH, A. G. and HARTWELL, L. H., 1995, A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell, 82, 841-847.
69. PETERSON, R. D. A. and FUNKHOUSER, J. D., 1989, Speculations on ataxia-telangiectasia: Defective regulation of the immunoglobulin gene superfamily. Immunology Today, 10, 313-315.
70. RUDOLPH, N. S., NAGASAWA, H., LITTLE, J. B. and LATT, S. A., 1989, Identification of ataxia telangiectasia heterozygotes by flow cytometric analysis of X-ray damage. Mutation Research, 211, 19-29.
71. SABATINI, D. M., ERDJUMENT-BROMAGE, H., LUI, M., TEMPST, P. and SNYDER, S. H., 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell, 78, 35-43.
72. SANAL, O., BERKEL, A. I., ERSOY, F., TEZCAN, I. and TOPAGLU, H., 1993, Clinical variants of ataxia-telangiectasia. In: Ataxia Telangioectasia NATO ASI Series, Series II: Cell Biology, Vol. 77. Edited by R. A. Gatti and R. B. Painter. (Springer, Berlin), pp. 183-189.
73. 2 phase x irradiation, a marker of the ataxia-telangiectasia gene. Journal of the National Cancer Institute, 82, 1050-1054.
74. SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., ZIV, Y., VANAGAITE, L., TAGLE, D. A., SMITH, S., UZIEL, T., SFEZ, S., ASHKENAZI, M. PECKER, I., ERYDMAN, M., HARNIK, R., PATANJALI, S. R., SIMMONS, A., CLINES, G. A., SARTIEL, A., GATTI, R. A., CHESSA, L., SANAL, O., LAVIN, M. F., JASPERS, N. G. J. and SHILOH, Y., 1995a, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753.
75. SAVITSKY, K., SFEZ, S., TAGLE, D. A., ZIV, Y., SARTIEL, A., COLLINS, F. S., SHILOH, Y. and ROTMAN, G., 1995b, The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Human Molecular Genetics, 4, 2025-2032.
76. SEATON, B. L., YUCEL, J., SUNNERHAGEN, P. and SUBRAMANI, S., 1992, Isolation and characterization of the Schizosaccharomyces pombe rad3 gene, involved in the DNA damage and DNA synthesis checkpoints. Gene, 119, 83-89.
77. SEDGWICK, R. P. and BODER, E., 1991, Ataxia-telangiectasia. In: Handbook of Clinical Neurology. Edited by P.J. Vinken, G. W. Bruyn and H. L. Klawans (Elsevier, New York), pp. 347-423.
78. SHERRINGTON, P. D., FISCH, P., TAYLOR, A. M. R. and RABBITTS, T. H., 1994, Clonal evolution of malignant and non-malignant T cells carrying t(14;14) and t(X;14) in patients with ataxia telangiectasia. Oncogene, 9, 2377-2381.
79. SHILOH, Y., 1995, Ataxia-telangiectasia: closer to unraveling the mystery. European Journal of Human Genetics, 3, 116-138.
80. SIPLEY, J. D., MENNINGER, J. C., HARTLEY, K. O., WARD, D. C., JACKSON, S. P. and ANDERSON, C. E., 1995, Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromosome 8. Proceedings of the National Academy of Sciences, USA, 92, 7515-7519.
81. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proceedings of the National Academy of Sciences, USA, 91, 5320-5324.
82. SLICHENMYER, W. J., NELSON, W. G., SLEBOS, R. J. and KASTAN, M. B., 1993, Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research, 53, 4164-4168.
83. SMITH, P. J. and PATERSON, M. C., 1983, Effect of aphidocolin on de novo DNA synthesis, DNA repair, and cytotoxicity in gamma-irradiated human fibroblasts: implications for the enhanced radiosensitivity in ataxia telangiectasia. Biochimica et Biophysica Acta, 739, 17-26.
84. STERN, M.-H., LIPKOWITZ, S., AURIAS, A., GRISCELLI, G., THOMAS, G. and KIRSCH, I. R., 1989, Inversion of chromosome 7 in ataxia telangiectasia is generated by a rearrangement between T-cell receptor tau genes. Blood, 6, 2076-2080.
85. 2/M by p53. Oncogene, 10, 109-115.
86. SWIFT, M., 1994, Ionizing radiation, breast cancer, and ataxia-telangiectasia. Journal of the National Cancer Institute, 86, 1571-1573.
87. SWIFT, M., 1995, Cancer mortality and low closes of ionising radiation. Lancet, 345, 253.
88. SWIFT, M., MORRELL, D., MASSEY, R. B. and CHASE, C. L., 1991, Incidence of cancer in 161 families affected by ataxia-telangiectasia. New England Journal of Medicine, 325, 1831-1836.
89. SWIFT, M., MORRELL, D., MASSEY, R. B. and CHASE, C. L., 1992, Risk of breast cancer in ataxia-telangiectasia. Reply. New England Journal of Medicine, 326, 1360-1361.
90. SWIFT, M., REITNAUER, P. J., MORRELL, D. and CHASE, C. L., 1987, Breast and other cancers in families with ataxia-telangiectasia. New England Journal of Medicine, 316, 1289-1294.
91. TACCIOLI, G. E., GOTTLIEB, T. M., BLUNT, T., PRIESTLEY, A., DEMENGEOT, J., MIZUTA, R., LEHMANN, A. R., ALT, F. W., JACKSON, S. P. and JEGGO, P. A., 1994, Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science, 265, 1442-1445.
92. TAKAI, S., SANFORD, K. K. and TARONE, R. E., 1990, A procedure for carrier detection in ataxia-telangiectasia. Cancer Genetics and Cytogenetics, 46, 139-140.
93. TAYLOR, A. M., FLUDE, E., LAHER, B., STACEY, M., MCKAY, E., WATT, J., GREEN, S. H. and HARDING, A. E., 1987, Variant forms of ataxia telangiectasia. Journal of Medical Genetics, 24, 669-677.
94. TAYLOR, A. M. R., HARNDEN, D. G., ARLETT, C. F., HARCOURT, S. A., LEHMANN, A. R., STEVENS, S. and BRIDGES, B. A., 1975, Ataxia telangiectasia: a mutation with abnormal radiation sensitivity. Nature, 258, 427-429.
95. TAYLOR, A. M. R., MCCONVILLE, C. M., ROTMAN, G., SHILOH, Y. and BYRD, P. J., 1994, A haplotype common to intermediate radiosensitivity variants of ataxia-telangiectasia in the UK. International Journal of Radiation Biology, 66(suppl.), S35-41.
96. TAYLOR, A. M. R., MCCONVILLE, C. M., WOODS, C. G., BYRD, P. J. and HERNANDEZ, D., 1993, Clinical and cellular heterogeneity in ataxia telangiectasia. In: Ataxia Telangiectasia. NATO ASI Series: II, Vol. 77. Edited by R. A. Gatti and R. B. Painter (Springer, Berlin), pp. 209-234.
97. THICK, J., SHERRINGTON, P. D., FISCH, P., TAYLOR, A. M. R. and RABBITTS, T. H., 1992, Molecular analysis of a new translocation, t(X;14)(q28;q11), in a premalignancy and in leukaemia associated with ataxia telangiectasia. Genes, Chromosomes and Cancer, 5, 321-325.
98. THOMPSON, L. H. and JEGGO, P. A., 1995, Nomenclature of human genes involved in ionizing radiation sensitivity. Mutation Research, 337, 131-134.
99. WAGNER, L. K., 1992, Risk of breast cancer in ataxia-telangiectasia. New England Journal of Medicine, 326, 1358.
100. WALDMANN, T. A., BRODER, S., GOLDMAN, C. K., FROST, K., KORSMEYER, S. J. and MEDICI, M.A., 1983a, Disorders of B cells and helper T cells in the pathogenesis of immunoglobulin deficiency of patients with ataxia-telangiectasia. Journal of Clinical Investigations, 71, 282-295.
101. WALDMANN, T. A., MISITI, J., NELSON, D. L. and KRAEMER, K. H., 1983b, Ataxia-telangiectasia: A multisystem hereditary disease with immunodeficiency, impaired organ maturation, x-ray hypersensitivity, and a high incidence of neoplasia. Annals of Internal Medicine, 99, 367-379.
102. WEEKS, D. E., PATERSON, M. C., LANGE, K., ANDRAIS, B., DAVIS, R. C., YODER, F. and GATTI, R. A., 1991, Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiation Research, 128, 90-99.
103. ZAKIAN, V. A., 1995, ATM-related genes: what do they tell us about functions of the human gene? Cell, 82, 685-687.
104. ZAMPETTI-BOSSELER, F. and SCOTT, D., 1981, Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation. International Journal of Radiation Biology, 5, 547-558.